Cra Intl Inc Stock Price, News & Analysis

Charles River Associates (NASDAQ: CRAI) announced the appointment of Patricia Thomas as a Vice President in its Forensic Services Practice. With 15 years of expertise, Thomas specializes in compliance, investigations, and litigation support across more than 25 countries. She has previously collaborated with key government agencies such as the Department of Justice and the FDIC. CRA's leadership expressed enthusiasm about her joining to enhance their investigative services aimed at clients' complex needs, particularly in compliance risk.

Charles River Associates (NASDAQ: CRAI) announced the appointment of Dr. Alva H. Taylor to its Board of Directors, effective August 1, 2022. Dr. Taylor, a professor at the Tuck School of Business, brings expertise in digital strategy and change management. His role includes serving on the Audit and Nominating and Corporate Governance Committees. Concurrently, Nancy Hawthorne has stepped down from the Board to focus on personal commitments. The leadership change follows a period of profitable growth for the consulting firm, indicating a strategic move towards continued success.

Charles River Associates (CRAI) announced that it will host a webcast for its second-quarter 2022 financial results on August 4, 2022, at 10:00 a.m. ET. The call will feature insights from CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes. Investors can access the live webcast on CRA's Investor Relations page. Pre-call materials, including a press release and supplemental financial information, will be available online. An archived version of the event will be accessible for one year.

Charles River Associates (CRAI) has launched its innovative Healthcare Claims Analytics Platform (HCAP) at the World Orphan Drug Congress USA 2022 in Boston. This new modular analytics tool aims to enhance decision-making for clients by analyzing patient, healthcare practitioner, and healthcare organization data. Developed over 18 months by CRA's Life Sciences Practice, HCAP supports advanced analytics, clinical trial strategies, and market insights. CRA's commitment to innovation is evident in this launch, designed to meet the needs of biotech and pharmaceutical firms globally.

Charles River Associates (NASDAQ: CRAI) will participate in the 12th Annual East Coast IDEAS Investor Conference Virtual Event on June 22, 2022. The company’s leadership, including CEO Paul Maleh, CFO Daniel Mahoney, and Chief Corporate Development Officer Chad Holmes, will engage in virtual one-on-one meetings with investors. CRA specializes in economic, financial, and management consulting services, providing solutions for complex business and regulatory challenges. More information is available at www.crai.com.

Charles River Associates (NASDAQ: CRAI) announced its participation in the Sidoti & Company Summer Virtual Small Cap Conference on June 15, 2022. The Company’s Chairman and CEO, Paul Maleh, will present at 9:15 a.m. ET. A live webcast is available on the Company's investor relations website, allowing online attendees to submit questions for a virtual Q&A session. Additionally, Maleh, along with CFO Daniel Mahoney and Chad Holmes, the Chief Corporate Development Officer, will hold virtual one-on-one meetings with investors.

Charles River Associates (NASDAQ: CRAI) has appointed David Cowen as Vice President in their Forensic Services practice. With over 25 years of experience in digital forensics and cybersecurity, Cowen is recognized for his expertise in addressing fraud, cybercrime, and compliance issues. He previously co-founded a consulting firm acquired by a Big Four accounting firm, emphasizing the company's commitment to enhancing its forensic capabilities. CRA's Forensic Services team is ISO 27001:2013 certified, ensuring high standards in information security.

Charles River Associates (NASDAQ: CRAI) has appointed Joshua Gans as a Senior Consultant in the Antitrust & Competition Economics Practice at its Toronto office. Gans, a distinguished professor from the University of Toronto, brings extensive expertise in innovation competition and economics, particularly concerning digital markets and AI. His appointment aims to enhance CRA’s analytical capabilities in providing economic analysis and testimony in global antitrust matters. Gans has authored numerous publications and is recognized for his impactful contributions to regulatory discussions.

Charles River Associates (NASDAQ: CRAI) reported record quarterly revenue of $148.4 million for Q1 fiscal 2022, marking a 1.3% year-over-year increase. Net income rose 8.8% to $11.4 million, with earnings per diluted share increasing 13.4% to $1.52. The company also reaffirmed its full-year revenue guidance of $585 million to $605 million. Additionally, CRA returned $7.4 million to shareholders through dividends and share repurchases. The strong performance was supported by double-digit revenue growth across five business practices.